A randomised-controlled Phase I de-escalation trial of Molnupiravir and Nirmatrelvir/Ritonavir combination for mild-moderate SARS-CoV-2 infectionSaye Khoo, Gareth Griffiths, Christopher J Edwards et al.|medRxiv|2025Cited by 1